Avipero Ltd - Company Review
Avipero Ltd - Company ReviewSummary
Avipero Ltd (Avipero) is a developer of therapeutics for unmet clinical needs. The company’s therapeutic target include Beta1 Integrin, a molecule on the surface of cells and facilitates adhesion or stickiness of the cell to its surrounding. Its treatment agent is an antibody that prevents tissue damage. Avipero provides treatment of various debilitating and degenerative conditions such as parkinson’s disease, emphysema in chronic obstructive pulmonary disease, arthritis, activation as a marker for asthma, activator for beta 1 integrin, evaluation methos and method for screening skin aging improving agent, skin aging preventive and age related cell decline. The company partners with pharmaceutical companies for research and development activities. Avipero is headquartered in Edinburgh, the UK.
This comprehensive company report of Avipero Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.